The prospect of orally administered monoclonal secretory IgA (SIgA) antibodies to prevent enteric bacterial infections
Eliminating diarrheal diseases as a leading cause of childhood morbidity and mortality in low- and middle-income countries (LMICs) will require multiple intervention strategies. In this review, we spotlight a series of preclinical studies investigating the potential of orally administered monoclonal...
Furkejuvvon:
| Váldodahkkit: | , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Taylor & Francis Group
2022-04-01
|
| Ráidu: | Human Vaccines & Immunotherapeutics |
| Fáttát: | |
| Liŋkkat: | http://dx.doi.org/10.1080/21645515.2021.1964317 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|